公开(公告)号：US09751878B2

公开(公告)日：2017-09-05

申请号：US15139531

申请日：2016-04-27

Applicant: Takeda Pharmaceutical Company Limited

Inventor： Shizuo Kasai ,  Hideki Hirose ,  Takeshi Yamasaki ,  Tohru Yamashita ,  Asato Kina ,  Yoichi Nishikawa

IPC: C07D471/04

CPC classification number: C07D471/04

Abstract: A compound having an SSTR5 antagonist action and use of the compound as a medicament are provided. Specifically, a compound represented by the following formula: wherein each symbol is as defined herein, or a salt thereof, a medicament comprising the compound or a salt thereof, and use of the compound or a salt thereof as an agent for the prophylaxis or treatment of diabetes mellitus are provided.

公开(公告)号：US20150119412A1

公开(公告)日：2015-04-30

申请号：US14525593

申请日：2014-10-28

Applicant: Takeda Pharmaceutical Company Limited

Inventor： Shizuo Kasai ,  Takashi Nakahata ,  Asato Kina ,  Hideki Hirose ,  Takeshi Yamasaki ,  Tohru Yamashita ,  Yoichi Nishikawa

IPC: C07D401/12 ,  C07D239/22 ,  C07D211/86

CPC classification number: C07D401/12 ,  C07D211/86 ,  C07D239/22 ,  C07D401/04 ,  C07D401/14

Abstract: A compound having an SSTR5 antagonist action and use of the compound as a medicament are provided. Specifically, a compound represented by the following formula: wherein each symbol is as defined herein, or a salt thereof, a medicament comprising the compound or a salt thereof, and use of the compound or a salt thereof as an agent the prophylaxis or treatment of diabetes mellitus are provided.

Abstract translation: 提供具有SSTR5拮抗作用的化合物和该化合物作为药物的用途。 具体地，由下式表示的化合物或其盐，其中每个符号如本文所定义，或其盐，包含该化合物或其盐的药物，以及该化合物或其盐的用途作为预防或治疗 提供糖尿病。

公开(公告)号：US09605000B2

公开(公告)日：2017-03-28

申请号：US14775265

申请日：2014-03-13

Applicant: Takeda Pharmaceutical Company Limited

Inventor： Shizuo Kasai ,  Masaki Ogino ,  Ryo Mizojiri ,  Takeshi Yamasaki ,  Hideki Hirose ,  Nobuyuki Takakura ,  Tohru Yamashita ,  Sachie Morimoto ,  Takashi Nakahata ,  Asato Kina

IPC: C07D498/10 ,  A61P3/00 ,  A61K31/424

CPC classification number: C07D498/10

Abstract: Provided is a compound represented by the following formula (1) or a salt thereof, which has an SSTR5 antagonistic action: wherein each symbol has the same definition as in the specification.

公开(公告)号：US09353108B2

公开(公告)日：2016-05-31

申请号：US14505907

申请日：2014-10-03

Applicant: Takeda Pharmaceutical Company Limited

Inventor： Shizuo Kasai ,  Hideki Hirose ,  Takeshi Yamasaki ,  Tohru Yamashita ,  Asato Kina

IPC: C07D471/04

CPC classification number: C07D471/04

Abstract: A compound having an SSTR5 antagonist action and use of the compound as a medicament are provided. Specifically, a compound represented by the following formula: wherein each symbol is as defined herein, or a salt thereof, a medicament comprising the compound or a salt thereof, and use of the compound or a salt thereof as an agent for the prophylaxis or treatment of diabetes mellitus are provided.

Abstract translation: 提供具有SSTR5拮抗作用的化合物和该化合物作为药物的用途。 具体地，由下式表示的化合物或其盐，其中每个符号如本文所定义，或其盐，包含该化合物或其盐的药物，以及该化合物或其盐作为预防或治疗剂的用途 的糖尿病。

公开(公告)号：US09120777B2

公开(公告)日：2015-09-01

申请号：US14525593

申请日：2014-10-28

Applicant: Takeda Pharmaceutical Company Limited

Inventor： Shizuo Kasai ,  Asato Kina ,  Hideki Hirose ,  Takeshi Yamasaki ,  Tohru Yamashita ,  Yoichi Nishikawa

IPC: C07D401/12 ,  C07D211/86 ,  C07D239/22

CPC classification number: C07D401/12 ,  C07D211/86 ,  C07D239/22 ,  C07D401/04 ,  C07D401/14

Abstract: A compound having an SSTR5 antagonist action and use of the compound as a medicament are provided. Specifically, a compound represented by the following formula: wherein each symbol is as defined herein, or a salt thereof, a medicament comprising the compound or a salt thereof, and use of the compound or a salt thereof as an agent the prophylaxis or treatment of diabetes mellitus are provided.

Abstract translation: 提供具有SSTR5拮抗作用的化合物和该化合物作为药物的用途。 具体地，由下式表示的化合物或其盐，其中每个符号如本文所定义，或其盐，包含该化合物或其盐的药物，以及该化合物或其盐的用途作为预防或治疗 提供糖尿病。

公开(公告)号：US20140243310A1

公开(公告)日：2014-08-28

申请号：US14353622

申请日：2012-10-23

Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED

Inventor： Tohru Yamashita ,  Takuya Fujimoto ,  Ryo Mizojiri ,  Kazuko Yonemori ,  Hideki Hirose ,  Zenichi Ikeda ,  Ikuo Fujimori ,  Kyoko Toyofuku ,  Tsuneo Yasuma ,  Nobuyuki Matsunaga

IPC: C07D231/56 ,  C07D498/04 ,  C07D307/80 ,  C07D413/04 ,  C07D263/57 ,  C07D235/18

CPC classification number: C07D231/56 ,  A61K31/343 ,  A61K31/416 ,  A61K31/4184 ,  A61K31/422 ,  A61K31/423 ,  A61K31/437 ,  A61K31/4439 ,  C07D235/18 ,  C07D263/57 ,  C07D307/80 ,  C07D413/04 ,  C07D498/04 ,  C07D513/04

Abstract: The present invention provides a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.

Abstract translation: 本发明提供由式（I）表示的化合物：其中每个符号如说明书中所定义，或其盐。

公开(公告)号：US11939327B2

公开(公告)日：2024-03-26

申请号：US17819818

申请日：2022-08-15

Applicant: Takeda Pharmaceutical Company Limited

Inventor： Tomoaki Hasui ,  Shinji Nakamura ,  Satoshi Mikami ,  Tohru Yamashita

IPC: C07D471/04 ,  C07D407/12 ,  C07D413/10 ,  C07D413/14

CPC classification number: C07D471/04 ,  C07D407/12 ,  C07D413/10 ,  C07D413/14

Abstract: The present invention aims to provide a heterocyclic compound having an AMPA receptor potentiator effect, which is expected to be useful as an agent for the prophylaxis or treatment of depression, Alzheimer's disease, schizophrenia, attention deficit hyperactivity disorder (ADHD) and the like.
The present invention relates to a compound represented by the formula (I):




wherein each symbol is as described in the specification, or a salt thereof.

公开(公告)号：US11447488B2

公开(公告)日：2022-09-20

申请号：US16753630

申请日：2018-10-04

Applicant: Takeda Pharmaceutical Company Limited

Inventor： Tomoaki Hasui ,  Shinji Nakamura ,  Satoshi Mikami ,  Tohru Yamashita

IPC: C07D471/04 ,  C07D407/12 ,  C07D413/10 ,  C07D413/14

Abstract: The present invention aims to provide a heterocyclic compound having an AMPA receptor potentiator effect, which is expected to be useful as an agent for the prophylaxis or treatment of depression, Alzheimer's disease, schizophrenia, attention deficit hyperactivity disorder (ADHD) and the like.
The present invention relates to a compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof.

公开(公告)号：US11407748B2

公开(公告)日：2022-08-09

申请号：US16753613

申请日：2018-10-04

Applicant: Takeda Pharmaceutical Company Limited

Inventor： Shinji Nakamura ,  Satoshi Mikami ,  Tomoaki Hasui ,  Tohru Yamashita ,  Shinji Morimoto ,  Hidekazu Tokuhara ,  Norio Oyabu ,  Masami Yamada ,  Atsuko Ochida ,  Kazuaki Takami ,  Xin Liu

IPC: A61K31/519 ,  C07D471/04 ,  C07D487/04 ,  A61K9/20 ,  C07D519/00

Abstract: The present invention aims to provide a heterocyclic compound having an AMPA receptor potentiator effect, which is expected to be useful as an agent for the prophylaxis or treatment of depression, Alzheimer's disease, schizophrenia, attention deficit hyperactivity disorder (ADHD) and the like.
The present invention relates to a compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof.

公开(公告)号：US20160237087A1

公开(公告)日：2016-08-18

申请号：US15139531

申请日：2016-04-27

Applicant: Takeda Pharmaceutical Company Limited

Inventor： Shizuo Kasai ,  Hideki Hirose ,  Takeshi Yamasaki ,  Tohru Yamashita ,  Asato Kina ,  Yoichi Nishikawa

IPC: C07D471/04

CPC classification number: C07D471/04

Abstract: A compound having an SSTR5 antagonist action and use of the compound as a medicament are provided. Specifically, a compound represented by the following formula: wherein each symbol is as defined herein, or a salt thereof, a medicament comprising the compound or a salt thereof, and use of the compound or a salt thereof as an agent for the prophylaxis or treatment of diabetes mellitus are provided.

Abstract translation: 提供具有SSTR5拮抗作用的化合物和该化合物作为药物的用途。 具体地，由下式表示的化合物或其盐，其中每个符号如本文所定义，或其盐，包含该化合物或其盐的药物，以及该化合物或其盐作为预防或治疗剂的用途 的糖尿病。